Articles tagged with Chronic Obstructive Pulmonary Disease
Acute COPD exacerbations significantly increase the risk of heart attack and stroke in people with cardiovascular disease or at high CVD risk. Researchers found that odds of these events were nearly four-fold higher within 30 days after an exacerbation.
UK researchers have made a breakthrough in treating severe lung disease by developing a home ventilation therapy that reduces hospital readmissions. The study, published in the Journal of the American Medical Association, found patients using this treatment were two-thirds less likely to be readmitted within 28 days.
Researchers found no evidence of increased risk of heart attack, depression, or self-harm in patients with COPD using varenicline. The medication is considered highly effective in helping smokers quit, addressing long-standing concerns among doctors.
A new study investigates the use of oxygen therapy via high-flow nasal tubes in patients with COPD experiencing exacerbations. The short-term trial found lower retained carbon dioxide levels compared to standard oxygen therapy, suggesting a potential benefit.
A new triple inhaler has shown a 20% reduction in chronic obstructive pulmonary disease (COPD) flare-ups in a year-long trial involving 2,691 patients. The study found that the inhaler improved lung function and reduced symptoms, with potential benefits for early diagnosis and targeted treatment.
A new study found that stem cell therapy reduces lung inflammation in a mouse model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The treatment also improves lung structure, suggesting it may repair damaged lungs.
A new study reveals a significant decrease in airway wall cells and certain inflammatory cells in smokers and mild to moderate COPD patients. The findings challenge the widely accepted description of airway inflammation in these individuals, suggesting a more complex underlying mechanism.
The new guidelines cover antibiotic and corticosteroid therapy for outpatients with mild and moderate exacerbations. The recommendations also include starting pulmonary rehabilitation 3 weeks after discharge from hospital following a severe exacerbation.
Researchers discovered that cigarette smoke silences the lung's natural self-healing process by blocking key receptors. Increasing these receptors can restore repair and lead to increased production of vital proteins, offering new hope for developing therapies for COPD patients.
A diet rich in fruit and vegetables is associated with a significantly lower risk of chronic lung disease (COPD) in former and current smokers. The study found that each additional daily serving was linked to a 4-8% lower risk, with the strongest influence coming from apples, green leafy vegetables, and peppers.
Current and former smokers with medical comorbidities are more likely to use e-cigarettes, which may be seen as a safer alternative to combustible cigarettes. The study found that e-cigarette use continues to rise, especially among present smokers with asthma or cardiovascular disease.
A study analyzing over 1.5 million Medicare records found that ICU care for COPD, heart failure, and heart attack patients may not be more beneficial than regular hospital care, with significant differences in cost of care.
A new treatment targeting COPD and other lung diseases has been identified in a study published in The FASEB Journal. FPS-ZM1, a RAGE antagonist compound, reverses the inflammatory response and has a protective role in COPD, according to researchers.
Researchers have identified 13 new genetic regions linked to chronic obstructive pulmonary disease (COPD), as well as overlap with asthma and pulmonary fibrosis. The study provides insight into the genetic basis of COPD and may lead to improved therapies for patients.
Scientists have developed a model to predict the chances of developing COPD, a deadly lung disease, based on genetic variations and smoking habits. The study, involving over 350,000 participants from 13 countries, has identified new genetic variants associated with enhanced or worsened lung function in smokers and non-smokers.
A new study found that dying at home or in hospital is influenced by factors such as wealth, location, and the presence of multiple diseases. The study showed a decrease in hospital deaths from COPD and IPD after implementing an end-of-life care strategy, but did not see this effect for patients with multimorbidity.
A new study found that sepsis accounts for the highest rate of hospital readmissions and associated costs among four tracked conditions, including heart attack, heart failure, COPD, and pneumonia. The study highlights the need to improve sepsis outcomes and reduce readmissions.
Researchers developed a new mouse model that faithfully reproduces the pathologies of COPD and CF, revealing two key pathways: oxidative stress and protease-antiprotease imbalance. The model shows promise for developing new medication therapies.
A study on chronic obstructive pulmonary disease (COPD) found that 44% of patients were under-treated, while only 19% received recommended medication regimens. Patients who were under-treated had fewer exacerbations, indicating that ignoring guidelines may be beneficial in certain cases.
Scientists at Helmholtz Zentrum München discovered that the Wnt5a molecule disrupts lung cells' ability to repair damages in COPD. Stimuli like cigarette smoke lead to increased production of Wnt5a, impairing lung regeneration.
Researchers are developing new technologies to help patients with chronic conditions such as COPD and diabetes manage their health at home. The £10 million project will explore the use of wearable devices and data analytics to improve healthcare services. Seven UK universities and over 30 partners are involved in the research.
A study of 129,535 Americans aged 50+ found that never-smoking older African American women had the highest COPD prevalence, with 7% and 5.2% in White women, respectively. Hormones and second-hand smoke exposure may contribute to this vulnerability.
Patients with chronic lung disease living in deprived areas are more likely to be malnourished than those from wealthier postcodes. A QUT study assessing 424 outpatients found 22% were at risk of malnutrition, with those from more deprived areas significantly more likely to be at risk.
Researchers found that patients with pulmonary function testing had a lower risk of hospitalization and death from COPD. The study suggests that increasing testing for suspected cases could improve patient care and reduce healthcare costs.
Researchers develop a simple tool to identify patients with chronic obstructive pulmonary disease (COPD) in primary care settings using five questions and peak expiratory flow meters. The approach shows high sensitivity and specificity rates, and may improve COPD diagnosis, quality of life, and health outcomes.
Researchers have developed a device that mimics the effects of cigarette smoke on human lungs, providing new insights into how non-smokers and COPD patients respond to smoke. The device enables the comparison of physiological responses in healthy individuals and COPD patients before and after exposure to cigarette smoke.
Scientists created an airway-on-a-chip that simulates the effects of smoking on human lungs, revealing changes in gene expression and cilia beat patterns. The technology also showed promise for testing e-cigarettes and identifying potential therapies for COPD.
A new study published in the New England Journal of Medicine found that long-term oxygen treatment does not improve survival or reduce hospital admissions for patients with chronic obstructive pulmonary disease (COPD) and moderately low blood oxygen levels. Researchers say these results underscore the need for new treatments for COPD.
Researchers studied COPD patients with moderate oxygen deficiency and found no significant difference in time to death, hospitalizations, or quality of life between those who received supplemental oxygen and those who didn't. The study suggests that long-term oxygen therapy may not be necessary for all COPD patients.
A recent study found that only 29% of patients with COPD had spirometry testing, leading to misdiagnoses in 31.6%. This highlights the need for education and training on COPD diagnosis to improve accuracy.
Two studies found that patients with a higher resting heart rate after an exacerbation are at risk for recurrent exacerbations, while hand grip strength is associated with fewer COPD exacerbations. Muscle weakness is linked to exercise limitation and exacerbations, making hand grip strength a useful marker.
A single home visit significantly increases patient adherence to office visits and inhaler use, reducing severe exacerbations and emergency department visits. After the intervention, patients exhibited a 40% decrease in ED visits and improved maintenance inhaler use.
Resveratrol, a compound found in red wine and grapes, has been shown to reduce inflammation induced by bacterial pathogens that cause respiratory diseases such as asthma and COPD. The study identified a novel mechanism by which resveratrol suppresses inflammation by upregulating a negative regulator called MyD88 short.
Research published in the American Journal of Respiratory and Critical Care Medicine found that acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with significant long-term lung function loss. Those with mild COPD experienced the greatest FEV1 decline, with each exacerbation linked to an additional 23 m...
Patients with chronic obstructive pulmonary disease (COPD) who engage in high levels of physical activity are less likely to develop anxiety or depression, with a 15% reduced risk. Mental disorders are common in COPD patients, affecting approximately 40% of the population.
A new study challenges the traditional efficacy trial model by using real-world patients and GP practices to test COPD treatments. The Salford Lung Study found that a once-daily treatment regimen was associated with lower rates of exacerbations without increased risk of serious adverse events.
Researchers analyzed 4,500 US hospitals' data and found that facilities with high readmission rates had better mortality scores in specific conditions like heart failure, COPD, and stroke. This challenges the commonly used measure of hospital quality by CMS.
Experts predict a significant increase in lung disease cases due to rising smoking rates and longer life expectancy, with over 1.3 million cases projected in England by 2030. The condition is expected to cost £2.5 billion annually, with more women than men affected, mainly due to their longer average lifespan.
Recent literature suggests N-acetylcysteine reduces frequency of COPD exacerbations in stable patients taking 1,200 mg daily. However, its benefits for acute exacerbations are uncertain and require further investigation.
Researchers found that new opioid use among older adults with chronic obstructive pulmonary disease (COPD) is associated with a significantly increased risk of respiratory-related complications and death. The study, published in the European Respiratory Journal, suggests that even lower-dose opioids may pose risks for this population.
A simple 7-item screening tool has been developed to identify patients at risk for chronic obstructive pulmonary disease (COPD). The tool uses predictive factors such as gender, age, smoking history, and breathlessness to assess COPD risk in primary care settings.
A recent study found that depression decreases adherence to COPD maintenance medications in older adults, with average monthly adherence peaking at 57% and decreasing to 25% within six months. Clinicians should be aware of the development of depression in newly-diagnosed patients with COPD.
A quarter of COPD patients are frail but can respond favourably to exercise rehabilitation. Frail patients who completed the programme scored better in measures of breathlessness and exercise performance, with 61% no longer meeting frailty criteria after rehabilitation.
A new study from UTMB reveals that pulmonary rehabilitation therapy is underutilized despite its health benefits and cost-effectiveness in managing chronic obstructive pulmonary disease. The study found that the majority of economic burden of COPD stems from hospitalizations, which can be reduced by PR.
A study of 417,494 older adults with COPD, asthma, or both found a significant increase in nontuberculous mycobacteria pulmonary disease among current and former inhaled corticosteroid users. Researchers identified fluticasone as a potential contributor to the increased risk.
A new report highlights seven areas of focus within COPD care, including improving access to education, medications, and non-medication interventions. The report also emphasizes the need for more research funding and development of cost-effective treatments.
A landmark survey by the ATS and Sunovion Pharmaceuticals Inc. reveals that seven in ten pulmonologists believe hand-held small volume nebulizers are more effective than metered-dose inhalers (MDIs) for managing acute exacerbations of COPD, particularly in severe cases. The survey also highlights gaps in physicians' knowledge about tre...
A new study reveals that smokers without COPD diagnosis often experience respiratory symptoms, and those with 'normal' breathing tests still require medical attention. Researchers are exploring the use of bronchodilator medication to improve symptoms for this patient group.
A new study found that exacerbations in COPD patients are associated with excess loss of lung function, particularly in those with mild disease. The researchers analyzed data from over 2,800 patients and found that each exacerbation was linked to a decline in FEV1, the amount of air a person can forcefully blow out of their lungs.
Exacerbations of COPD accelerate lung-function loss among patients with mild disease, according to researchers. The study found that exacerbations resulted in significant additional decline in FEV1 lung function, particularly among GOLD 1 patients.
A new study has found that home-based pulmonary rehabilitation can be equally effective in improving fitness and quality of life for COPD patients as traditional center-based programs. The low-cost program resulted in comparable outcomes to the hospital-based program, with no significant differences in clinical outcomes at any time point.
A randomized study found that motivational interviewing-based health coaching reduced COPD-related readmission rates by 7.5% in the first month and 11% at 3 months post-discharge, leading to improved disease-specific quality of life.
Researchers discovered that NETs are strongly correlated with airway infection and disease severity in COPD patients, suggesting a potential biomarker for identifying those at risk of progression. This finding may lead to the development of new treatments targeting NET formation.
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the US, yet patients often face out-of-pocket costs and inadequate care. The Lancet Respiratory Medicine report highlights these challenges, including high medication costs and variable insurance coverage.
Charles Daley, Irina Petrache, and James Crapo receive awards for their work on tuberculosis diagnosis, women in pulmonary medicine, and COPD research respectively. The American Thoracic Society honors their contributions to improve patient outcomes in respiratory diseases.
A study published in the New England Journal of Medicine found a link between persistent childhood asthma and chronic obstructive pulmonary disease (COPD) in early adulthood. Children with low lung function at a young age were more likely to develop COPD later in life, regardless of treatment or smoking exposure.
A Vanderbilt University Medical Center study finds that persistent inflammation in COPD may result from a defect in the immune system allowing airway bacteria to invade deeper into the lungs. Treatment with an anti-inflammatory drug halted lung damage in mice with this defect.
A recent study published in JAMA Internal Medicine found significant disparities in healthcare quality for Hispanic Medicare Advantage enrollees in Puerto Rico compared to their counterparts in the US. The study analyzed data from over 7 million MA enrollees and found that Hispanic MA enrollees in Puerto Rico received worse care on 15 ...
Researchers discovered hidden mechanisms of the immune system in two disease areas, COPD and systemic lupus erythematosus. The findings showed that ILC2s can change into inflammatory cells in response to stimuli, suggesting a potential way to treat COPD exacerbations.
Non-invasive positive pressure ventilation enhances efficiency of pulmonary rehabilitation in patients with stable COPD, improving measures of shortness of breath and exercise tolerance. Patients experience significant relief from breathing difficulties during exercising, allowing for more effective pulmonary rehabilitation.